GP-Act III Acquisition Corp. — Form 8-K Summary
Reporting period and business context: The filing reports events related to the company’s initial public offering, priced on May 8, 2024 and stated to have closed on May 13, 2024. GP-Act III Acquisition Corp. is a Cayman Islands special purpose acquisition company (SPAC) seeking to complete an initial business combination.
Key financial and capital markets metrics
| Item | Amount or terms |
|---|---|
| Public units issued | 28,750,000 units, including 3,750,000 units from the underwriter’s over-allotment option |
| Public offering price | $10.00 per unit |
| Gross IPO proceeds | $287.5 million |
| Private placement warrants | 7,000,000 warrants sold at $1.00 each; stated gross proceeds of $7.0 million |
| Public warrant terms | Each whole warrant is exercisable for one Class A ordinary share at $11.50 per share, subject to adjustments |
| Trust account | The filing states that $287.5 million was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A.; the stated amount is inconsistent with the separately disclosed $287.5 million of IPO proceeds plus $7.0 million of private placement proceeds |
| Revenue, profit and cash flow | The filing does not provide operating revenue, net income, cash flow, margins or other income-statement metrics |
| Debt and liquidity | No debt balance or broader liquidity metrics are disclosed. IPO proceeds are subject to trust-account restrictions |
Material changes versus the prior comparable period
- The company completed its IPO and private warrant financing, establishing its initial capital base.
- The company entered into its principal IPO-related agreements, including the underwriting, trust, warrant, registration rights, administrative services and private placement agreements.
- No prior-period operating results are presented, so changes in revenue, profitability, margins or cash flow cannot be assessed.
Outlook, risks and unusual items
- Trust funds generally cannot be released until the completion of an initial business combination, specified shareholder redemptions or the redemption of public shares if no business combination is completed within 24 months after the IPO closing, subject to applicable law.
- The filing does not identify a target company, provide transaction guidance or state a projected business-combination timetable beyond the 24-month deadline.
- Private placement warrants have terms differing from public warrants: they are generally not redeemable, are subject to transfer restrictions until 30 days after the initial business combination, may be exercised cashlessly and carry registration rights.
- The filing contains a numerical inconsistency regarding the trust account: $287.5 million is described as consisting of IPO and private placement proceeds, although those separately reported proceeds total $294.5 million before expenses or other uses.
- The filing lists indemnity agreements with directors and officers and an administrative services agreement with the GP Sponsor.
Important facts for investors to verify
- Reconcile the trust-account balance and the disposition of the $7.0 million private placement proceeds.
- Confirm the actual IPO closing date and the resulting deadline for completing an initial business combination.
- Review the warrant agreement for redemption, adjustment, exercise and cashless-exercise provisions.
- Assess potential dilution from the 28.75 million public shares, public warrants and 7.0 million private placement warrants.
- Review the trust-account protections, shareholder redemption rights and consequences if no business combination is completed.